‌

US Patent 9447414 Methods and compositions involving miRNA and miRNA inhibitor molecules

Patent 9447414 was granted and assigned to Asuragen on September, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Asuragen

Current Assignee

Asuragen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

94474140

Patent Inventor Names

Eric Devroe0

Lance Ford0

Kevin Kelnar0

Rich Jarvis0

Mike Byrom0

Angie Cheng0

David Brown0

Dmitriy Ovcharenko0

Date of Patent

September 20, 2016

Patent Application Number

147410640

Date Filed

June 16, 2015

Patent Primary Examiner

‌

Brian Whiteman

Patent abstract

The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9447414 Methods and compositions involving miRNA and miRNA inhibitor molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API